Registered number
10470734
Multiply AI Limited
Filleted Accounts
31 December 2023
Multiply AI Limited
Registered number: 10470734
Balance Sheet
as at 31 December 2023
Notes 2023 2022
£ £
Fixed assets
Tangible assets 3 12,930 18,070
Current assets
Debtors 4 58,232 69,535
Cash at bank and in hand 132,083 1,115,906
190,315 1,185,441
Creditors: amounts falling due within one year 5 (214,659) (132,733)
Net current (liabilities)/assets (24,344) 1,052,708
Net (liabilities)/assets (11,414) 1,070,778
Capital and reserves
Called up share capital 1,980 1,980
Share premium 7,650,476 7,650,476
Share capital reserves 7 928,015 -
Profit and loss account (8,591,885) (6,581,678)
Shareholders' funds (11,414) 1,070,778
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Vivek Madlani
Director
Approved by the board on 25 September 2024
Multiply AI Limited
Notes to the Accounts
for the year ended 31 December 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Office equipment over 3 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2023 2022
Number Number
Average number of persons employed by the company 14 12
3 Tangible fixed assets
Office equipment
£
Cost
At 1 January 2023 40,739
Additions 2,566
Disposals (10,638)
At 31 December 2023 32,667
Depreciation
At 1 January 2023 22,669
Charge for the year 7,706
On disposals (10,638)
At 31 December 2023 19,737
Net book value
At 31 December 2023 12,930
At 31 December 2022 18,070
4 Debtors 2023 2022
£ £
Trade debtors 40,650 848
Other debtors 17,582 68,687
58,232 69,535
5 Creditors: amounts falling due within one year 2023 2022
£ £
Trade creditors 70,312 56,811
Taxation and social security costs 49,482 43,205
Other creditors 94,865 32,717
214,659 132,733
6 Going concern
The balance sheet at the end of 2023 recorded negative shareholder funds, however the Board were working on such a scenario and initiatives to resolve this are in train. Our Board initiated a successful equity funding round in the fourth quarter of 2023. The round has garnered significant interest, with capital inflows beginning in the second quarter of 2024. We are confidant in closing the round by the end of the year. The company successfully secured a steady stream of new clients from the fourth quarter of 2023 through 2024. We are optimistic about our continued growth and expect to welcome additional clients in the near future. The successful implementation of these initiatives has significantly improved our financial position. This strengthened financial foundation will enable us to effectively pursue our business objectives for 2024 and fulfil our obligations to our clients.
7 Share based payments
1. For the financial year ending 31 December 2023, the Company is recognising for the first time the accumulated staff expense for the granting of options to employees of £928,015. The Directors judged in earlier years that the expense associated with the granting of options was not significant to recognize, If recognized during the financial year ended 2022 the comparable expense would have been £49,734 using the same mechanics as used for the 2023 valuation. The full Profit and Loss and Shareholder Funds impact of all options granted has been processed through the 2023 accounts.
The comparative financial information for 2022 has been prepared on a consistent basis unless otherwise noted.
2. Description of the Share Option Plan: The Company operates an equity-settled, share-based compensation plan, under which it previously granted options to key employees as part of their remuneration package. There were no new share options granted during the current financial year. The plan includes options that vest over a period contingent upon continuing employment and meeting specified performance criteria.
3. Summary of Existing Option Pool: As of 31 December 2023, the Company has an existing pool of 47,554,042 options granted in prior years, some of which are still in the process of vesting. The options are exercisable at a price of £0.00001 per option and have the following vesting schedule and conditions:
Vesting period: 1, 2 and 4 years from the grant date.
Vesting conditions: Subject to the achievement of specific operational targets and continued employment.
4. Status of Vesting: As of 31 December 2023, 90% of the previously granted options have vested, with the remainder expected to vest over the next 3 years, assuming continuing employment and achievement of performance targets.
5. Expense Recognised: The total expense recognised for the year arising from the entity's share-based payment transactions amounted to 756,519. This represents the ongoing amortisation of the fair value of the options that were estimated at the grant date and is recognised on a graded vesting basis.
6. Reconciliation of Outstanding Options: A reconciliation of option movements during the year is as follows:
Description Number of Options Weighted Average Exercise Price
Outstanding at the beginning of the year 47,163,459 0.03056
Granted during the year 390,583 0.03141
Forfeited during the year - -
Exercised during the year - -
Expired during the year - -
Outstanding at the end of the year 47,554,042 0.03056
Exercisable at the end of the year 42,996,437 0.03072
8 Share based payments - Perfomance based options
1. Description of the Performance-based Share Option Plan: The Company has implemented a performance-based share option program targeted at senior management and key personnel. Under this program, options are granted that vest based on the achievement of specific performance targets linked to the Company's valuation performance over a specified period.
2. Summary of Grant Activity and Conditions: During the year ended 31 December 2023, the Company did not grant any performance-based options to senior executives. Previous options have been granted subject to vesting conditions based on the achievement of a pre-determined valuation of the Company.
3. Valuation of Options: The fair value of performance-based options granted was estimated at the grant date using a Monte Carlo simulation model, reflecting the likelihood of meeting the high market conditions specified. Key inputs to the model included:
Risk-free rate: 1.25%
Expected volatility: 35%
Expected dividends: Nil
Share price target: £0.0489
The fair value determined at the grant date was £0.01417 per option.
4. Expense Recognition: The total estimated expense of £51,656 is recognised over the vesting period adjusted for the company's revision of the probability that these performance conditions will be met. Changes in performance expectations or market conditions may lead to significant adjustments to the initially recognised amounts.
5. Reconciliation of Outstanding Options: A reconciliation of option movements during the year is as follows:
Description Number of Options Weighted Average Exercise Price
Outstanding at the beginning of the year 10,415,568 0.01417
Granted during the year - -
Forfeited during the year - -
Exercised during the year - -
Expired during the year - -
Outstanding at the end of the year 10,415,568 0.01417
Exercisable at the end of the year - -
6. Significant Adjustments: As at the year end the assessment of the probability of the performance based share options meeting their performance requirement was 50%. However, post year end the probability of meeting the requirement has risen to 85%.
9 Other information
Multiply AI Limited is a private company limited by shares and incorporated in England. Its registered office is:
24 Arlington Square
London
N1 7DP
The registered office moved from Rise London, 41 Luke Street, London, EC2A 4DP on 17 August 2023.
Multiply AI Limited 10470734 false 2023-01-01 2023-12-31 2023-12-31 VT Final Accounts April 2024 Vivek Madlani No description of principal activity 10470734 2022-01-01 2022-12-31 10470734 core:WithinOneYear 2022-12-31 10470734 core:ShareCapital 2022-12-31 10470734 core:SharePremium 2022-12-31 10470734 core:RetainedEarningsAccumulatedLosses 2022-12-31 10470734 2023-01-01 2023-12-31 10470734 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 10470734 bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 10470734 bus:Director40 2023-01-01 2023-12-31 10470734 1 2023-01-01 2023-12-31 10470734 2 2023-01-01 2023-12-31 10470734 core:PlantMachinery 2023-01-01 2023-12-31 10470734 countries:England 2023-01-01 2023-12-31 10470734 bus:FRS102 2023-01-01 2023-12-31 10470734 bus:FilletedAccounts 2023-01-01 2023-12-31 10470734 2023-12-31 10470734 core:WithinOneYear 2023-12-31 10470734 core:ShareCapital 2023-12-31 10470734 core:SharePremium 2023-12-31 10470734 core:RetainedEarningsAccumulatedLosses 2023-12-31 10470734 core:PlantMachinery 2023-12-31 10470734 2022-12-31 10470734 core:PlantMachinery 2022-12-31 iso4217:GBP xbrli:pure